dacarbazine has been researched along with Carcinoma, Large Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreassen, M; Clausen, MM; Kjær, A; Knigge, U; Langer, SW; Petersen, RH; Soldath, P; Ørting, AM | 1 |
| Earl, S; Gounaris, I; Lyons, B; Rahamim, J; Shivasankar, S; Yiannakis, D | 1 |
2 other study(ies) available for dacarbazine and Carcinoma, Large Cell
| Article | Year |
|---|---|
Treatment of inoperable large cell neuroendocrine lung cancer with single agent temozolomide.
Topics: Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Dacarbazine; Humans; Lung Neoplasms; Neuroendocrine Tumors; Temozolomide; Treatment Outcome | 2023 |
Marked response to a cisplatin/docetaxel/temozolomide combination in a heavily pretreated patient with metastatic large cell neuroendocrine lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Dacarbazine; Docetaxel; Fatal Outcome; Female; Humans; Lung Neoplasms; Middle Aged; Quality of Life; Taxoids; Temozolomide | 2007 |